Reply to: "Lack of a US Food and Drug Administration indication should not limit access to appropriate treatment".

Savage KT, Flood KS, Popatia S, et al. Reply to: "Lack of a US Food and Drug Administration indication should not limit access to appropriate treatment".. Journal of the American Academy of Dermatology. 2019;81(1):e19-e20.